This trial is evaluating whether Healthy Beginnings will improve 1 primary outcome and 2 secondary outcomes in patients with Body Weight. Measurement will happen over the course of Approximately 6 months (from 10-16 weeks gestation to 35-38 weeks gestation).
This trial requires 432 total participants across 2 different treatment groups
This trial involves 2 different treatments. Healthy Beginnings is the primary treatment being studied. Participants will all receive the same treatment. There is no placebo group. The treatments being tested are not being studied for commercial purposes.
Although the incidence of obesity in the United States has increased in the past 2 decades, the majority of Americans have low BMI. For this group of individuals, lifestyle improvements may reduce obesity rates at least as greatly as calorie-control dieting and exercising may for those with a BMI of 25 kg/m².
We investigated what it meant to be overweight and whether different factors might explain this discrepancy between health professionals and patients. Results from a recent paper will be useful for health professionals, health promotion workers and patients alike.
Treatment decisions for body weight are complicated by an individual patient's condition as well as by the side effects of treatment. When counseling a patient about treatment, it is important to first identify factors that may be contributing to difficulty in maintaining weight loss or achieving a gain. Common approaches include behavioral interventions, weight reduction, exercise, medications to control appetite, and weight maintenance.
We have demonstrated that overweight individuals who are able to achieve and maintain a weight within BMI target range have the lowest risk of developing cancer.
The majority of women and men who are obese perceive their weight as unhealthy and would like to lose weight; however, the majority of the population is not able to maintain their weight loss goals and is not satisfied with their weight status.
Obesity presents as the most important sign for detecting a high risk group, in which all persons need more preventive measures. Fatty liver disease is a marker for risk of future metabolic disorders. It could be an independent risk factor for the development of type 2 diabetes.
The present study indicates that for healthy weight participants, a weight control plan composed of four to six sessions with a supervised fitness instructor of regular weight and an attendance of regular fitness classes that take into account the participants' physical abilities is feasible and effective in reducing body weight. Results support an effect that does not depend on compliance and suggests that weight control is a simple, affordable intervention that is not only effective for weight loss, but may also affect some of the well-known cardiovascular health-related risk factors.
[Body weight fluctuation, age, gender and BMI are 4 main factors that influence body weight changes]{http://www.physiological-behavio[ra](https://www.withpower.com/clinical-trials/ra)l-basis.com/fitness/factors/[overweight](https://www.withpower.com/clinical-trials/overweight).html}. The most recent research has found that a [5-kgram (25-lb) overweight person's BMI rises by 1-point and an underweight person's BMI rises by 4-point, so the average BMI range is between 23 and 25. However, BMI is a relative-value indicator of fat-mass percentage while calculating a person's body fat percentage (FTF). The most recent research has been to use the method that calculates FTF as the most accurate.
Healthy beginnings encourages parents to recognize the early signs and symptoms and initiate routine check-ups of their child's growth and development. More importantly, early identification and treatment of any problems would avert long-term adverse health effects.
A growing body of evidence now demonstrates that obese individuals benefit from weight loss or maintenance in managing chronic disease as obese adults fare worse on many measures of quality of life than their less-obese counterparts.
The present study shows that the average age that men and women begin to attain body weights that are normal or prehypertensive is 13 years younger for men than for women (13.4 years vs. 15.7 years, respectively, P < 0.001).
In fact most available drug therapies may promote body weight gain. However even if clinical studies are undertaken to search for new compounds, many of them are very expensive because of the long time required to go through the preclinical phase while a new compound has to be introduced into the market or have an equivalent one. In this regard, as of 2014 few compounds from synthetic chemistry have been studied because the synthesis of many potential drugs are very expensive and many of them are difficult to obtain because of structural complexity and/or synthetic difficulties. In any case, it is very common that a company will decide to develop a drug that could also be considered a natural product of a fungal species, a plant species or as part of a bacterial species, etc.